Loading...
Loading...
India's tenofovir imports from UNITED STATES total $1.1M across 75 shipments from 15 foreign suppliers. ESPEE BIOPHARMA & FINECHEM LLC leads with $576.5K in import value; the top 5 suppliers together control 72.8% of this origin. Leading Indian buyers include MYLAN LABORATORIES LIMITED. This corridor reflects India's pharmaceutical import demand for tenofovir — a diversified sourcing base with multiple active suppliers from UNITED STATES.

ESPEE BIOPHARMA & FINECHEM LLC is the leading Tenofovir supplier from UNITED STATES to India, with import value of $576.5K across 22 shipments. The top 5 suppliers — ESPEE BIOPHARMA & FINECHEM LLC, Espee Biopharma & Finechem LLC, ESPEE BIOPHARMA & FINECHEM LLC., AGRACE PHARMA, NewLife Medicals (USA). Inc. — collectively account for 72.8% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ESPEE BIOPHARMA & FINECHEM LLC | $576.5K | 22 | 50.9% |
| 2 | Espee Biopharma & Finechem LLC | $92.9K | 7 | 8.2% |
| 3 | ESPEE BIOPHARMA & FINECHEM LLC. | $59.7K | 1 | 5.3% |
| 4 | AGRACE PHARMA | $51.8K | 5 | 4.6% |
| 5 | NewLife Medicals (USA). Inc. | $44.5K | 1 | 3.9% |
| 6 | PREMIUM HEALTH SERVICES,INC. | $44.2K | 1 | 3.9% |
| 7 | PREMIUM HEALTH SERVICES INC | $37.9K | 2 | 3.3% |
| 8 | AGRACE PHARMA. | $25.3K | 3 | 2.2% |
| 9 | NEWLIFE MEDICALS (USA) INC | $24.3K | 1 | 2.1% |
| 10 | SUN PHARMACEUTICAL INDUSTRIES INC. | $21.4K | 1 | 1.9% |
| 11 | PREMIUM HELTH SERVICES INC, | $19.9K | 1 | 1.8% |
| 12 | Premium Health Services, Inc. | $18.9K | 1 | 1.7% |
| 13 | AMSTERDAM PHARMA(APTEKA RX INC.) | $14.0K | 3 | 1.2% |
| 14 | M/S. PHARMACEUTICAL BUYERS, INC. | $12.4K | 3 | 1.1% |
| 15 | PHARMACEUTICAL BUYER .INC | $11.9K | 1 | 1.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | MYLAN LABORATORIES LIMITED | $202.2K | 15 | 17.8% |
| 2 | LAURUS LABS LIMITED | $202.2K | 10 | 17.8% |
| 3 | LUPIN LIMITED | $192.9K | 4 | 17.0% |
| 4 | EMCURE PHARMACEUTICALS LIMITED | $90.1K | 6 | 8.0% |
| 5 | HETERO LABS LIMITED | $72.8K | 7 | 6.4% |
| 6 | LAURUS LABS LTD | $64.1K | 1 | 5.7% |
| 7 | MICRO LABS LIMITED | $63.2K | 2 | 5.6% |
| 8 | AIZANT DRUG RESEARCH SOLUTIONS PRIVATE LIMITED | $55.0K | 4 | 4.9% |
| 9 | MACLEODS PHARMACEUTICALS LIMITED | $26.4K | 1 | 2.3% |
| 10 | DR.REDDY'S LABORATORIES LTD | $25.3K | 3 | 2.2% |
| 11 | AUROBINDO PHARMA LIMITED | $24.3K | 1 | 2.1% |
| 12 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $21.4K | 1 | 1.9% |
| 13 | CLIANTHA RESEARCH LIMITED | $19.9K | 1 | 1.8% |
| 14 | MACLEODS PHARMACEUTICALS LTD | $19.2K | 3 | 1.7% |
| 15 | AUROBINDO PHARMA LTD | $14.0K | 4 | 1.2% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Tenofovir suppliers from UNITED STATES to India include ESPEE BIOPHARMA & FINECHEM LLC, Espee Biopharma & Finechem LLC, ESPEE BIOPHARMA & FINECHEM LLC.. The leading supplier is ESPEE BIOPHARMA & FINECHEM LLC with import value of $576.5K USD across 22 shipments. India imported Tenofovir worth $1.1M USD from UNITED STATES in total across 75 shipments.
India imported Tenofovir worth $1.1M USD from UNITED STATES across 75 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Tenofovir sourced from UNITED STATES include MYLAN LABORATORIES LIMITED, LAURUS LABS LIMITED, LUPIN LIMITED. The largest buyer is MYLAN LABORATORIES LIMITED with $202.2K in imports across 15 shipments.
The total value of Tenofovir imports from UNITED STATES to India is $1.1M USD, across 75 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
75 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists